Bpifrance SA Long-Term Concentrated

Location: Maisons Alfort, Cedex, France

CIK: 0001731118 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $879M (100.0% shares, 0.0% debt)

Holdings (8)

FTI TECHNIPFMC PLC 65.7%

Value $578M Shares 24,688,691 Est. Cost $17.41 Unrealized -8.7%

— CONSTELLIUM NV 14.9%

Value $131M Shares 16,393,903 Est. Cost $6.99 Unrealized —

— TALEND S A 9.3%

Value $81.56M Shares 1,612,895 Est. Cost $37.08 Unrealized —

CRTO CRITEO S A 6.2%

Value $54.46M Shares 2,718,752 Est. Cost $22.72 Unrealized —

— MILLENDO THERAPEUTICS INC 1.8%

Value $16.18M Shares 1,078,670 Est. Cost $7.95 Unrealized —

— SEQUANS COMMUNICATIONS S A 1.5%

Value $13.31M Shares 12,085,561 Est. Cost $0.78 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 0.5%

Value $4.34M Shares 828,262 Est. Cost $3.15 Unrealized —

MITK MITEK SKS INC 0.1%

Value $548K Shares 44,754 Est. Cost $9.04 Unrealized +24.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
FTI	TECHNIPFMC PLC	24,688,691	$578M	65.7%	$17.41	-8.7%	COM	G87110105
—	CONSTELLIUM NV	16,393,903	$131M	14.9%	$6.99	—	CL A	N22035104
—	TALEND S A	1,612,895	$81.56M	9.3%	$37.08	—	ADS	874224207
CRTO	CRITEO S A	2,718,752	$54.46M	6.2%	$22.72	—	SPONS ADS	226718104
—	MILLENDO THERAPEUTICS INC	1,078,670	$16.18M	1.8%	$7.95	—	COM	60040X103
—	SEQUANS COMMUNICATIONS S A	12,085,561	$13.31M	1.5%	$0.78	—	SPONS ADS	817323108
—	ADVERUM BIOTECHNOLOGIES INC	828,262	$4.34M	0.5%	$3.15	—	COM	00773U108
MITK	MITEK SKS INC	44,754	$548K	0.1%	$9.04	+24.1%	COM NEW	606710200